Leflunomide monotherapy versus combination therapy with conventional synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: a retrospective study

Leflunomide (LEF) is a conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) for the treatment of rheumatoid arthritis. However, there are few reports on the comparison of efficacy between LEF alone and combined with other csDMARDs. Here, the efficacy and safety of LEF monotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Daihua, Zhou, Jun, Li, Min, Li, Siyin, Tian, Lan, Zou, Jinmei, Wang, Tingting, Wu, Jianhong, Zeng, Fanxin, Yang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378063/
https://www.ncbi.nlm.nih.gov/pubmed/32704073
http://dx.doi.org/10.1038/s41598-020-69309-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378063/
https://www.ncbi.nlm.nih.gov/pubmed/32704073
http://dx.doi.org/10.1038/s41598-020-69309-z

Ejemplares similares